Literature DB >> 3020493

Clinical overview of varicella vaccine: development and early studies.

M Takahashi.   

Abstract

A live varicella vaccine was developed in 1973 and has been used effectively and safely in normal as well as high-risk children. Some precautions are necessary for use in the high-risk children.

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 3020493

Source DB:  PubMed          Journal:  Pediatrics        ISSN： 0031-4005            Impact factor:   7.124


  10 in total

Review 1.  Molecular mechanisms of varicella zoster virus pathogenesis.

Authors:  Leigh Zerboni; Nandini Sen; Stefan L Oliver; Ann M Arvin
Journal:  Nat Rev Microbiol       Date:  2014-02-10       Impact factor: 60.633

2.  Rapid genotyping of varicella-zoster virus vaccine and wild-type strains with fluorophore-labeled hybridization probes.

Authors:  V N Loparev; K McCaustland; B P Holloway; P R Krause; M Takayama; D S Schmid
Journal:  J Clin Microbiol       Date:  2000-12       Impact factor: 5.948

3.  Improved identification and differentiation of varicella-zoster virus (VZV) wild-type strains and an attenuated varicella vaccine strain using a VZV open reading frame 62-based PCR.

Authors:  V N Loparev; T Argaw; P R Krause; M Takayama; D S Schmid
Journal:  J Clin Microbiol       Date:  2000-09       Impact factor: 5.948

4.  Experimental infection of Cynomolgus Macaques (Macaca fascicularis) with human varicella-zoster virus.

Authors:  David O Willer; Aruna P N Ambagala; Richard Pilon; Jacqueline K Chan; Jocelyn Fournier; James Brooks; Paul Sandstrom; Kelly S Macdonald
Journal:  J Virol       Date:  2012-01-18       Impact factor: 5.103

5.  Interferon Gamma Inhibits Varicella-Zoster Virus Replication in a Cell Line-Dependent Manner.

Authors:  Akhalesh K Shakya; Seong K Kim; Dennis J O'Callaghan
Journal:  J Virol       Date:  2019-05-29       Impact factor: 5.103

6.  Varicella-zoster virus infection induces autophagy in both cultured cells and human skin vesicles.

Authors:  Marie-Noëlle Takahashi; Wallen Jackson; Donna T Laird; Timothy D Culp; Charles Grose; John I Haynes; Luca Benetti
Journal:  J Virol       Date:  2009-03-18       Impact factor: 5.103

7.  Varicella-zoster-virus vaccination in immunosuppressed children with rheumatic diseases using a pre-vaccination check list.

Authors:  Fabian Speth; Claas H Hinze; Susanne Andel; Thomas Mertens; Johannes-Peter Haas
Journal:  Pediatr Rheumatol Online J       Date:  2018-03-02       Impact factor: 3.054

8.  Live Attenuated Varicella Vaccine: Prevention of Varicella and of Zoster.

Authors:  Anne A Gershon; Michael D Gershon; Eugene D Shapiro
Journal:  J Infect Dis       Date:  2021-09-30       Impact factor: 5.226

Review 9.  Why are vaccines against many human viral diseases still unavailable; an historic perspective?

Authors:  Gregory A Tannock; Hyunsuh Kim; Lumin Xue
Journal:  J Med Virol       Date:  2019-10-03       Impact factor: 2.327

Review 10.  A review of licensed viral vaccines, some of their safety concerns, and the advances in the development of investigational viral vaccines.

Authors:  David B Huang; Jashin J Wu; Stephen K Tyring
Journal:  J Infect       Date:  2004-10       Impact factor: 6.072
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.